2022 Vol. 4, No. 14
2022, 4(14): 288-292.
doi: 10.46234/ccdcw2022.071
Abstract:
What is already known about this topic? COVID-19 vac ded by this report? Among person
cines are important tools to protect populations from severe disease and death. What is ad
s aged ≥60 years in Hong Kong, 49%, had received ≥2 doses of a COVID-19 v...
2022, 4(14): 293-297.
doi: 10.46234/ccdcw2022.074
Abstract:
What is already known about this topic? Compared wit
h the international mRNA and adenovirus-vectored coronavirus disease 2019 (COVID-19) vaccines, there is less real-world research data about breakthrough cases in people vaccinated with China-made C...
2022, 4(14): 298-301.
doi: 10.46234/ccdcw2022.064
Abstract:
What is already known about this topic? Aerosol tran
smission is one route for the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, uncertainty remains on the threshold of ventilation rate in its occurrence. What is a...